{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T21:33:49Z","timestamp":1780090429243,"version":"3.54.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.phrs.2017.06.002","type":"journal-article","created":{"date-parts":[[2017,6,10]],"date-time":"2017-06-10T03:00:55Z","timestamp":1497063655000},"page":"105-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["The effect of statins on cardiovascular outcomes by smoking status: A systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"122","author":[{"given":"Sorin","family":"Ursoniu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri P.","family":"Mikhailidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Corina","family":"Serban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Penson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Ridker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kausik K.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kees Hovingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Kastelein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian V.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnn E.","family":"Manson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Rysz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2017.06.002_bib0005","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/bmj.321.7257.323","article-title":"Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies","volume":"321","author":"Peto","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2017.06.002_bib0010","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.phrs.2017.06.002_bib0015","series-title":"WHO Global Report: Mortality Attributable to Tobacco. 2012","first-page":"1","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.phrs.2017.06.002_bib0020","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3390\/ijerph8020613","article-title":"Hazardous compounds in tobacco smoke","volume":"8","author":"Talhout","year":"2011","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.phrs.2017.06.002_bib0025","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrcardio.2014.26","article-title":"Epidemiological studies of CHD and the evolution of preventive cardiology","volume":"11","author":"Wong","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.phrs.2017.06.002_bib0030","doi-asserted-by":"crossref","first-page":"e1000873","DOI":"10.1371\/journal.pgen.1000873","article-title":"Deciphering normal blood gene expression variation\u2014the NOWAC postgenome study","volume":"6","author":"Dumeaux","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.phrs.2017.06.002_bib0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1755-8794-3-29","article-title":"Transcriptomic epidemiology of smoking: the effect of smoking on gene expression in lymphocytes","volume":"3","author":"Charlesworth","year":"2010","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.phrs.2017.06.002_bib0040","doi-asserted-by":"crossref","first-page":"e10693","DOI":"10.1371\/journal.pone.0010693","article-title":"Genetics and beyond\u2014the transcriptome of human monocytes and disease susceptibility","volume":"5","author":"Zeller","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2017.06.002_bib0045","doi-asserted-by":"crossref","first-page":"e90314","DOI":"10.1371\/journal.pone.0090314","article-title":"The effects of smoking on levels of endothelial progenitor cells and microparticles in the blood of healthy volunteers","volume":"9","author":"Mobarrez","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2017.06.002_bib0050","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.phrs.2015.03.009","article-title":"Lipids, blood pressure and kidney update 2014","volume":"95\u201396C","author":"Banach","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2017.06.002_bib0055","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.06.002_bib0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12916-016-0550-5","article-title":"Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro\/con debate","volume":"14","author":"Hobbs","year":"2016","journal-title":"BMC Med."},{"key":"10.1016\/j.phrs.2017.06.002_bib0065","first-page":"MS1","article-title":"Time for new indications for statins?","volume":"15","author":"Banach","year":"2009","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.phrs.2017.06.002_bib0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2011.06.028","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"217","author":"Catapano","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2017.06.002_bib0075","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/000331970105200901","article-title":"Smoking diminishes the beneficial effect of statins: observations from the landmark trials","volume":"52","author":"Milionis","year":"2001","journal-title":"Angiology"},{"key":"10.1016\/j.phrs.2017.06.002_bib0080","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2017.06.002_bib0085","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. 0 [updated March 2011]","author":"Green","year":"2011"},{"key":"10.1016\/j.phrs.2017.06.002_bib0090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.phrs.2017.06.002_bib0095","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.phrs.2017.06.002_bib0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2307\/2530643","article-title":"Estimation of a common effect parameter from sparse follow-up data","volume":"41","author":"Greenland","year":"1985","journal-title":"Biometrics"},{"key":"10.1016\/j.phrs.2017.06.002_bib0105","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2017.06.002_bib0110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/aje\/kwn340","article-title":"More than numbers: the power of graphs in meta-analysis","volume":"169","author":"Bax","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.phrs.2017.06.002_bib0115","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L\u2019Abbe","year":"1987","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.phrs.2017.06.002_bib0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1536867X0400400204","article-title":"Funnel plots in meta-analysis","volume":"4","author":"Sterne","year":"2004","journal-title":"Stata J."},{"key":"10.1016\/j.phrs.2017.06.002_bib0125","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Stat. Med."},{"key":"10.1016\/j.phrs.2017.06.002_bib0130","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2017.06.002_bib0135","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/sim.4780101105","article-title":"A general parametric approach to the meta-analysis of randomized clinical trials","volume":"10","author":"Whitehead","year":"1991","journal-title":"Stat. Med."},{"key":"10.1016\/j.phrs.2017.06.002_bib0140","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0140-6736(97)08461-4","article-title":"Overcoming the limitations of current meta-analysis of randomised controlled trials","volume":"351","author":"Pogue","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2017.06.002_bib0145","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2017.06.002_bib0150","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2017.06.002_bib0155","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2017.06.002_bib0160","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group","volume":"339","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2017.06.002_bib0165","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2017.06.002_bib0170","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2174\/1570161111311050016","article-title":"The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study","volume":"11","author":"Athyros","year":"2013","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.phrs.2017.06.002_bib0175","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2017.06.002_bib0180","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2017.06.002_bib0185","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2017.06.002_bib0190","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstrom","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2017.06.002_bib0195","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2017.06.002_bib0200","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/ATVBAHA.113.300156","article-title":"Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis","volume":"34","author":"Messner","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2017.06.002_bib0205","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1165\/ajrcmb.19.5.3091","article-title":"Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells","volume":"19","author":"Su","year":"1998","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.phrs.2017.06.002_bib0210","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1164\/ajrccm.164.4.2101023","article-title":"Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers","volume":"164","author":"Barbera","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.phrs.2017.06.002_bib0215","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1096\/fj.07-099481","article-title":"VEGFR-2 inhibition augments cigarette smoke-induced oxidative stress and inflammatory responses leading to endothelial dysfunction","volume":"22","author":"Edirisinghe","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2017.06.002_bib0220","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.2174\/138161210792062830","article-title":"Adverse effects of cigarette smoke and induction of oxidative stress in cardiomyocytes and vascular endothelium","volume":"16","author":"Varela-Carver","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phrs.2017.06.002_bib0225","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.06.002_bib0230","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2174\/157016107782023406","article-title":"Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms","volume":"5","author":"Rahman","year":"2007","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.phrs.2017.06.002_bib0235","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0033-0620(03)00087-2","article-title":"Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment","volume":"46","author":"Benowitz","year":"2003","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.phrs.2017.06.002_bib0240","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/em.21850","article-title":"Epigenetic epidemiology: promises for public health research","volume":"55","author":"Bakulski","year":"2014","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.phrs.2017.06.002_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-015-0148-3","article-title":"DNA methylation changes of whole blood cells in response to active smoking exposure in adults: a systematic review of DNA methylation studies","volume":"7","author":"Gao","year":"2015","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.phrs.2017.06.002_bib0250","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.atherosclerosis.2015.05.022","article-title":"Statin therapy reduces plasma endothelin-1 concentrations: a meta-analysis of 15 randomized controlled trials","volume":"241","author":"Sahebkar","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2017.06.002_bib0255","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12916-015-0459-4","article-title":"Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies","volume":"13","author":"Banach","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.phrs.2017.06.002_bib0260","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1160\/th15-08-0620","article-title":"The impact of statin therapy on plasma levels of von Willebrand factor antigen. Systematic review and meta-analysis of randomised placebo-controlled trials","volume":"115","author":"Sahebkar","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.phrs.2017.06.002_bib0265","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1042\/CS20060033","article-title":"Atorvastatin normalizes endothelial function in healthy smokers","volume":"111","author":"Agewall","year":"2006","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.phrs.2017.06.002_bib0270","first-page":"597","article-title":"Tobacco smoking, paraoxonase-1 (PON1) activity and pleiotropic effects of simvastatin treatment in patients with stable coronary artery disease (CAD)","volume":"72","author":"Januszek","year":"2015","journal-title":"Przegl. Lek."},{"key":"10.1016\/j.phrs.2017.06.002_bib0275","doi-asserted-by":"crossref","first-page":"e005455","DOI":"10.1136\/bmjopen-2014-005455","article-title":"Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study","volume":"5","author":"Ogawa","year":"2015","journal-title":"BMJ Open"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817306795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817306795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T14:53:49Z","timestamp":1583938429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661817306795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":55,"alternative-id":["S1043661817306795"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2017.06.002","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of statins on cardiovascular outcomes by smoking status: A systematic review and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2017.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}